Report Overview

The EU Sleeping Medication market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Sleeping medications are commonly known as sleeping pills. Sleeping pills mainly refers to a generic term used for describing both over-the-counter (OTC) or prescription medications. Sleeping pills are majorly used for helping individuals who face difficulty in falling asleep as well as staying asleep on their own. Such pills are generally hypnotics which promote or extend the duration of sleep. These pills are also act as sedatives, as they promote calming effect and also they have the ability to cause drowsiness. Sleeping medications also have serious side effects such as heart attacks, stroke or even life-threatening diseases, if abused or overused. According to research, women are more prone to suffer from insomnia than men. Thus, the consumption rate of sleeping medications is higher among women than men



Market Drivers

The factors driving the market growth are, increasing healthcare expenditure are also propelling expansion in the European sleeping medications market. Along with this, rising awareness regarding the importance of ample sleep is also stoking demand in the European sleeping medications market